Consegna (ASX:CGP) said two thirds of athletes trialling the prototype of the sport version of its BreatheAssist device felt they were able to take more air into their lungs. [ + ]

NICTA is leading a multimillion-dollar project that will use big data and machine learning to deliver new insights into the natural sciences. [ + ]

Pharmaceuticals company Mega Lifesciences is expanding its Australian business operations with the opening of an $8 million manufacturing plant in Pakenham, Victoria. [ + ]

Mesoblast (ASX:MSB) has secured a Japanese patent offering broad protection for its MPC adult stem cell platform in the market through to 2025. [ + ]

Australian intellectual property advisory firm FB Rice has appointed two new partners for its Melbourne biotechnology and chemistry practice. [ + ]

The Science of Learning Research Centre has received significant funding from the Australian Government to investigate the neuroscience of the human learning process. [ + ]

University of Washington engineers, with spin-out company NanoFacture, have developed a device that can simply and efficiently extract human DNA from fluid samples, making it ready for analysis and genome sequencing in minutes. [ + ]

PathoGenetix, a commercial-stage developer of an automated system for rapid bacterial identification, has announced research demonstrating the use of genome sequence scanning (GSS) technology to confirm and identify pathogenic Salmonella strains in enriched spinach samples in less than 5 h. [ + ]

CSIRO scientists have developed the first safety test for iPS cells. [ + ]

ResMed (ASX:RMD) has launched a new online - and soon mobile - app to help sleep-disordered breathing patients track their therapy progress and set goals. [ + ]

A new Cooperative Research Centre (CRC) for Manufacturing Industry Innovation (MIICRC) invites organisations to participate as industry partners. [ + ]

Australian research has found that daily use of broad-spectrum sunscreen slows the ageing process of skin, as well as preventing skin cancer. [ + ]

Immuron (ASX:IMC) has dissolved its relationship with ANZ distributor Takeda and will start selling its flagship Travelan product directly to wholesalers in the markets. [ + ]

Research into a blowfly protein will not only enable farmers to design more effective pesticides, but it may also pave the way to an antidote for chemical warfare agents such as sarin gas. [ + ]

Qiagen has announced two agreements adding promising new biomarkers involving glioblastoma, lymphoma and other cancers to the company’s expanding portfolio of potential companion diagnostics. [ + ]